| Interest of APA in Fatty Liver Disease Evaluation of Efficacy and Adherence to an Adapted Physical Activity (APA) Program in Patients With Metabolic Fatty Liver Disease (NCT04835831) | Centre Hospitalier Universitaire de Nice | 2021-09-15 |
| Clinical, Biochemical and Body Composition Analysis in Assessment of Steatosis in Non Alcoholic Fatty Liver Disease (NCT04946786) | Sohag University | 2021-07-01 |
| A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG) (NCT04820036) | Brigham and Women's Hospital | 2021-05-06 |
| Combined Active Treatment in Type 2 Diabetes With NASH (NCT04639414) | German Diabetes Center | 2021-03-26 |
| NASH Patient's Itinerary: Comparison of Strategies for Screening, Referring and Management of Diabetic Patients (NCT06688149) | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 2021-01-31 |
| The Sonic Incytes Liver Incytes System, Evaluation of Liver Fibrosis and Steatosis Versus MRE and MRI PDFF (NCT04682600) | Sonic Incytes | 2020-10-21 |
| Metabolic Surgery for Steato-Hepatitis (NCT04282005) | King's College London | 2020-02-13 |
| Evaluation of Multi-Organ Metabolism and Perfusion in NAFLD by Total Body Dynamic PET Scan on EXPLORER (NCT04165343) | University of California, Davis | 2019-11-01 |
| Diagnosis and Characterization of Non-Alcoholic Fatty Liver Disease Based on Artificial Intelligence. (NCT04099147) | Instituto de Investigación Marqués de Valdecilla | 2019-09-30 |
| A Study to Evaluate Safety and Pharmacodynamic Efficacy of 0382 in Obese Subjects With NAFLD/NASH. (NCT04019561) | MedImmune LLC | 2019-09-23 |
| Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease (NCT04330326) | ScandiBio Therapeutics AB | 2019-07-20 |
| A Study To Assess Pharmacodynamics, Safety And Tolerability Of PF-05221304 And PF-06865571 Co-Administered For 6 Weeks In Adults With Non-Alcoholic Fatty Liver Disease. (NCT03776175) | Pfizer | 2019-01-04 |
| Longitudinal Observational Study Of Chinese With NAFLD/NASH (NCT03151473) | Humanity and Health Research Centre | 2017-05-08 |
| Non-alcoholic Fatty Liver Disease Parametric PET (FLiPP) Study (NCT02754037) | University of California, Davis | 2016-04-30 |
| Use of a Novel Drug in People With Non-alcoholic Steatohepatitis (NASH) or Non-alcoholic Fatty Liver Disease (NAFLD) (NCT02605616) | University of Alabama at Birmingham | 2015-11-01 |
| A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweight Subjects. (NCT02354976) | AstraZeneca | 2015-09-01 |
| Improving Insulin Resistance To Treat Non-Alcoholic Fatty Liver Disease: A Pilot Study (NCT02457286) | Northwell Health | 2015-06-01 |
| "Hepafast" in Non-alcoholic Fatty Liver Disease (NAFLD) (NCT02491229) | University of Hohenheim | 2015-01-01 |
| The Effect of Acetaminophen on Non-alcoholic Fatty Liver Disease Patients (NCT02194894) | University of Southern California | 2014-06-01 |
| Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults (NCT02654665) | Changi General Hospital | 2014-03-01 |
| Dietary Intervention and Intestinal Microbiota in Non-alcoholic Fatty Liver (NCT01477307) | University Hospital, Geneva | 2013-07-01 |
| Study to Assess the Efficacy, Safety and Tolerability of LCQ908 in NAFLD Patients (NCT01811472) | Novartis Pharmaceuticals | 2013-06-01 |
| Association of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus (NCT01997424) | Johann Wolfgang Goethe University Hospital | 2013-05-01 |
| Meta-Analyses of the Effect of Plant Protein Versus Animal Protein on Cardiometabolic Risk (NCT02037321) | John Sievenpiper | 2013-05-01 |
| Mediterranean Lifestyle Intervention in Patients With Non-alcoholic Fatty Liver Disease (NCT01894438) | Harokopio University | 2013-04-01 |
| Combined Intensive and Conventional Exercise on Nonalcoholic Fatty Liver Disease (NAFLD) (NCT01418027) | Shanghai Jiao Tong University School of Medicine | 2011-08-01 |
| Study of Magnetic Resonance Imaging (MRI) to Quantify Liver Fat in Diabetic and Pre-Diabetic Patients (0000-171) (NCT01110577) | Merck Sharp & Dohme LLC | 2010-05-01 |
| Regulation of FGF21 by Nutritional Challenges (NCT00968747) | Beth Israel Deaconess Medical Center | 2009-07-01 |
| How Does Dietary Carbohydrate Influence the Formation of an Atherogenic Lipoprotein Phenotype (ALP)? (NCT01790984) | Bruce A. Griffin | 2009-04-01 |
| Potential Role of n-3 Fatty Acids in the Treatment of NAFLD in Pediatric Patients (NCT02201160) | St. Justine's Hospital | 2009-01-01 |
| Non Alcoholic Fatty Liver Disease Influence of Statin Therapy (NCT00375349) | Shaare Zedek Medical Center | 2006-09-01 |
| Exercise Dose and Nonalcoholic Fatty Liver Disease (NCT00771108) | Washington University School of Medicine | 2006-05-01 |